B. Gwiosda: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

PCN120 COST-UTILITY OF DOCETAXEL COMPARED WITH BEST SUPPORTIVE CARE AND PEMETREXED IN SECOND LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN POLAND

J Rutkowski, B Gwiosda, B Lisiecka, M Wladysiuk, J Lis, R Plisko, P Rys

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 81 KB

english, 2009

2

PCV55 BUDGET IMPACT ANALYSIS OF DIAGNOSTIC OF UNEXPLAINED AND/OR RECURRENT SYNCOPE WITH APPLICATION OF IMPLANTABLE LOOP RECORDER

B Gwiosda, I Palka, D Karas, M Wladysiuk, D Szmurlo, J Rutkowski, R Plisko, P Rys

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 77 KB

english, 2009

3

PMH21 BUDGET IMPACT ANALYSIS OF DULOXETINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER

B Gwiosda, J Rutkowski, P Rys, R Plisko, M Wladysiuk, M Cel, P Mierzejewski, W Bartminski

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 80 KB

english, 2009

4

PIN2 Safety and Efficacy of Tenofovir as Compared to Other Nucleot(s)ide Analogues in the Treatment of Chronic Hepatitis B – A Systematic review with Mixed Treatment Comparison

P. Wojciechowski, A. Stozek, J. Szmyd, B. Gwiosda, P. Mierzejewski, M. Kazmierski, P. Rys, M. Wladysiuk, R. Plisko

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 57 KB

english, 2011

5

PIN79 Cost-Utility Analysis of Tenofovir in Comparison with Other Nucleoside Analogues (AN) in Chronic Hepatitis B (CHB) Treatment

B. Gwiosda, J. Krzystek, G. Niesyczynski, K. Osiewalski, P. Mierzejewski, M. Kazmierski, M. Wladysiuk, R. Plisko

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 60 KB

english, 2011

6

PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)

B. Gwiosda, J. Krzystek, P. Rys, M. Wladysiuk, P. Mierzejewski, M. Kazmierski, R. Plisko

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 72 KB

english, 2011

7

PND32 Cost-Utility Analysis of Ropinirole in Parkinson'S Disease (PD) Treatment

I. Zerda, A. Drozdz, D. Brzyski, M. Pochopien, B. Gwiosda, B. Lisiecka, D. Barlog, C. Glogowski, D. Dziurda, P. Rys, R Plisko

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 61 KB

english, 2011

8

PIN66 Constant Vs Time-Dependent: Two Different Approaches to Determine Transition Probabilities Between Health States in Modeling the Course of Disease – The Case of Hepatitis C

Szmurlo, D., Brzyski, D., Fundament, T., Gwiosda, B., Wladysiuk, M.

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

9

PRM80 Proportional Hazards Assumption and Its Impact on Results of Cost-Effectiveness Analysis

Pochopien, M., Zerda, I., Gwiosda, B., Plisko, R.

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 59 KB

english, 2012

10

PRM82 Verification of Proportional Hazards Assumption in Cost-Effectiveness Analysis (CEA)

Zerda, I., Gwiosda, B., Plisko, R.

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски